Document Detail

Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
MedLine Citation:
PMID:  20102304     Owner:  NLM     Status:  MEDLINE    
IMPORTANCE OF THE FIELD: Primary biliary cirrhosis is a cholestatic liver disease that at one time was the leading indication for liver transplantation. Treatment with ursodeoxycholic acid has clearly improved the natural history of primary biliary cirrhosis.
AREAS COVERED IN THIS REVIEW: The treatment of primary biliary cirrhosis with a focus on ursodeoxycholic acid is covered. Papers related to treatment of primary biliary cirrhosis and associated conditions, using a variety of drugs but with a focus on ursodeoxycholic acid, are included. The papers reviewed date from 1984 - 2009.
WHAT WILL THE READER GAIN: The reader will gain an up-to-date understanding of current treatment strategies for primary biliary cirrhosis using ursodeoxycholic acid and an appreciation of what conditions are improved with this therapy and what associated conditions are not.
TAKE-HOME MESSAGE: Ursodeoxycholic acid in a dose of 13 - 15 mg/kg/day should be considered in all patients with primary biliary cirrhosis who have abnormal liver enzymes.
Ghulam Abbas; Keith D Lindor
Related Documents :
674624 - The effect of nonfractionated and fractionated administration of iopanoic acid on gallb...
2307404 - Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ...
8536824 - Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver ...
2353164 - Decreased concentrations of deoxycholic acid in serum of uraemic patients with diarrhoea.
8143754 - A new method for the determination of the cytotoxicity of bile acids and aqueous phase ...
19100704 - Photostabilization of bacillus thuringiensis fermented wastewater and wastewater sludge...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  11     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-27     Completed Date:  2010-04-30     Revised Date:  2012-09-10    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  387-92     Citation Subset:  IM    
Mayo Clinic, Division of Gastroenterology and Hepatology, 20 First Street SW, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Administration Schedule
Drug Therapy, Combination
Immunosuppressive Agents / administration & dosage,  therapeutic use*
Liver Cirrhosis, Biliary / drug therapy*,  enzymology
Mitochondria, Liver / enzymology*
Treatment Outcome
Ursodeoxycholic Acid / administration & dosage,  therapeutic use*
Reg. No./Substance:
0/Immunosuppressive Agents; 128-13-2/Ursodeoxycholic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacotherapy of major depressive disorder in adolescents.
Next Document:  Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.